Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings

NCT01654848 is registered in ClinicalTrials.gov with CHIR-Net as lead sponsor.

NCT NCT01654848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01654848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings
Lead sponsor
CHIR-Net
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2011
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia, liver transplantation